🔎 Trials Near Me

Home › Lung Cancer › Virginia › Arlington

Lung Cancer clinical trials in Arlington, VA

41 studies for Lung Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RecruitingPhase 3
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

RecruitingPhase 2
  • Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06780098

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

RecruitingPhase 3
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

RecruitingPhase 3
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

RecruitingPhase 1
  • PHN-012-001 Site, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07127874

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

RecruitingPhase 1
  • Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi away
  • Inova Schar Cancer, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07519655

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

RecruitingPhase 2
  • Research Site, Fairfax · 11 mi away
Ages 18 to 95 · All sexes · Updated Sep 23, 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

RecruitingPhase 2/3
  • Virginia Cancer Specialists - Arlington, Arlington
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

RecruitingPhase 1/2
  • Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

RecruitingPhase 1
  • NEXT - Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07349537

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

RecruitingPhase 3
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07625644

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

RecruitingPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • USO - Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06561685

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

RecruitingPhase 1/2
  • Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi away
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

RecruitingPhase 1
  • NEXT Oncology, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome
  • Inova Schar Cancer Institute, Fairfax · 11 mi away
  • Inova Fair Oaks Hospital, Fairfax · 11 mi away
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

RecruitingPhase 3
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06712355

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

RecruitingPhase 3
  • Inova Schar Cancer Institute, Fairfax · 11 mi away
  • Inova Fair Oaks Hospital, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06500481

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07444814

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

RecruitingPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05652686

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

RecruitingPhase 1
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07315113

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

RecruitingPhase 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT06162221

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

RecruitingPhase 1
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RecruitingPhase 1
  • Research Site, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06835569

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi away
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

RecruitingPhase 1
  • NEXT Oncology Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

RecruitingPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT07223047

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

RecruitingPhase 1/2
  • Next Oncology Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

RecruitingPhase 1/2
  • NEXT Oncology, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi away
18 Minutes · All sexes · Updated May 5, 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2/3
  • Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi away
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06616584

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

RecruitingPhase 2
  • Inova Fairfax Hospital, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05456256

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

RecruitingPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT07020221

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

RecruitingPhase 1/2
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • NEXT Virginia, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT05948865

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

RecruitingPhase 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06244771

About Lung Cancer

Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

More about Lung Cancer on MedlinePlus

Lung Cancer trials in other cities

Other studies in Arlington

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.